As per this study, the Global HbA1c Testing Market was valued at USD 2.3 BN (by revenue) in 2021 and is anticipated to reach USD 4.34 BN by 2028 with a CAGR of 9.5%.
Hemoglobin A1C is mostly abbreviated as HbA1c, it is a form of hemoglobin (a blood pigment that carries blood) which is bound to glucose. This test is basically carried out in people with type 1 and type 2 diabetes. The level HBA1c shows how well diabetes is controlled in the individual. The normal range for HBA1c is less than 6%. They are also known as glycosylated, or glycated hemoglobin.
Market Dynamics
The growth of the HbA1c testing market is mainly growing on the ground of rising number of diabetes population. Moreover, the advent of new technologies in diabetes management along with the rising awareness of diabetes among people is further expected to propel the growth. Increasing medical tourism in developing nations is likely to open a new opportunity for the market. On the other hand, the high cost of the device is likely to hamper the growth of the market.
This detailed market study is centered on the data obtained from multiple sources and is analyzed using numerous tools including porter's five forces analysis, market attractiveness analysis and value chain analysis. These tools are employed to gain insights of the potential value of the market facilitating the business strategists with the latest growth opportunities. Additionally, these tools also provide a detailed analysis of each application/product segment in the global market of HbA1c testing.
Market Segmentation
The broad HbA1c testing market has been sub-grouped into device type, technology and end-user. The report studies these subsets with respect to the geographical segmentation. The strategists can gain a detailed insight and devise appropriate strategies to target specific market. This detail will lead to a focused approach leading to identification of better opportunities.
By Device Type
- Handheld Device
- Bench-Top Device
By Technology
- Ion-exchange HPLC
- Enzymatic assay
- Affinity binding chromatography
- Turbidimetric inhibition immunoassay
- Other
By End-User
- Hospital
- Homecare
- Diagnostic Laboratory
Regional Analysis
Furthermore, the report comprises of the geographical segmentation which mainly focuses on current and forecast demand for HbA1c testing in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The report further focuses on demand for individual application segments in all the regions.
Global HbA1c Testing Market Share by Region (Representative Graph)
The report also covers detailed competitive landscape including company profiles of key players operating in the global market. The key players in the HbA1c testing market include Abbott Laboratories, Alere, Inc., Arkray, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Siemens Healthcare, Transasia Biomedicals ltd., and Trinity Biotech plc. An in-depth view of the competitive outlook includes future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other developments with information in terms of H.Q.
In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.